BLLSF (BioLight Life Sciences) FCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BLLSF BioLight Life Sciences Ltd BLLSF
16 GF Score
Price $0.09
! 3 Warning Signs
View Full Analysis

What is BioLight Life Sciences FCF Margin %?

BioLight Life Sciences BLLSF 16 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates BLLSF with a GF Score™ of 16/100. The stock has 3 warning signs investors should review. Among 953 Biotechnology companies, BioLight Life Sciences ranks worse than 104931.69% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BioLight Life Sciences's Free Cash Flow for the six months ended in Dec. 2025 was $-1.81 Mil. BioLight Life Sciences's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, BioLight Life Sciences's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, BioLight Life Sciences's current FCF Yield % is -32.39%.

The historical rank and industry rank for BioLight Life Sciences's FCF Margin % or its related term are showing as below:


During the past 13 years, the highest FCF Margin % of BioLight Life Sciences was -679.30%. The lowest was -354333.33%. And the median was -7174.07%.

BLLSF's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -79.91
* Ranked among companies with meaningful FCF Margin % only.

BioLight Life Sciences FCF Margin % Related Terms

BioLight Life Sciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for BioLight Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioLight Life Sciences FCF Margin % Chart

BioLight Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -350,900.00 -15,042.86 -9,302.56 -5,051.39 0.00

BioLight Life Sciences Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5,103.57 -3,947.37 -6,111.43 0.00 0.00

BLLSF vs VRTX, REGN, RVMD: FCF Margin % Comparison

For the Biotechnology subindustry, BioLight Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioLight Life Sciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLight Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BioLight Life Sciences's FCF Margin % falls into.


BLLSF
16GF Score
BioLight Life Sciences Ltd BLLSF
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioLight Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BioLight Life Sciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-3.584/0
= %

BioLight Life Sciences's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.812/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
BioLight Life Sciences (BLLSF) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BioLight Life Sciences and its competitors. According to the industry distribution chart, BioLight Life Sciences ranks #999999 out of 953 companies in the Biotechnology industry.
Is BioLight Life Sciences' FCF Margin % too high?
BioLight Life Sciences' current FCF Margin % is 0.00%. Based on the distribution chart, BioLight Life Sciences ranks #999999 out of 953 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, BioLight Life Sciences has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does BioLight Life Sciences' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BioLight Life Sciences ranks #999999 out of 953 companies for FCF Margin %. This places BioLight Life Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BioLight Life Sciences and its competitors. BioLight Life Sciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioLight Life Sciences stock overvalued right now?
BioLight Life Sciences (BLLSF) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. BioLight Life Sciences' overall GF Score™ is 16/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For BioLight Life Sciences (BLLSF), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioLight Life Sciences Business Description

Other Exchanges BOLT:Israel
Address Aba Hillel Silver 12, 11 floor, Ramat Gan, ISR, 5250606
BioLight Life Sciences Ltd is an emerging ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.
16GF Score

Get the complete analysis for BLLSF

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price